Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare…
| Price | $311.80 |
|---|---|
| Market cap | $60.66B |
| Sector | Healthcare |
| Industry | Medical - Distribution |
| Exchange | NYSE |
| 52-week range | 244.82-377.54 |
| Dividend (TTM) | $2.40 per share |
| Beta | 0.57 |
Explore COR's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.